Astelles will be providing unique insights into operational challenges at the 8th annual Paediatric Clinical Trials event taking place in 3 weeks’ time.

LONDON, LONDON, UNITED KINGDOM, March 11, 2014 /EINPresswire.com/ -- Industry thought leaders will gather together in London on 31st March at the 8th annual conference on Paediatric Clinical Trials, as they discuss ways to identify key factors that influence study design and optimize operational execution of paediatric clinical trials, global paediatric legislations, ethical considerations PIP submission plus much more.

The two day event features newly added presentations including a keynote address from Astelles, the updated brochure is available to download online at www.paediatric-trials.co.uk. For further insights, visit the download tab to read exclusive short interviews with some key speakers including Novartis, Paediatric Research Consultancy and Empowering Children - Enabling Research.

Heavy in continuing education and networking, the conference aims to provide a platform for those who study and practice in the field. A snap shot of confirmed attendees include:

• Actelion
• Agence Francaise De Securite Sanitaire Des Produits De Sante
• Astellas
• Austrian Agency for Health and Food Safety
• Bayer Pharma AG
• COGSTATE LTD
• Consortium for Biological and Pharmacological Evaluations (CVBF)
• Empowering Children | Enabling Research
• F. Hoffmann-La Roche
• Ghent University Hospital
• GRiP Network of Excellence
• Jenny Walsh Consulting
• Klausrose Consulting
• L2D consulting
• Lundbeck
• Medicines for Children Research Network (MCRN)
• Novartis
• Novartis Vaccines
• Opsona Therapeutics Ltd
• Paediatric Research Consultancy
• Pharmavision
• PPD Inc.
• Prince Sultan Military Medical City
• Quintiles
• Roche Pharmaceuticals
• Svabhegy Paediatric Hospital
• TAKEDA
• University of Copenhagen


With the event taking place in just 3 weeks' time, places are now limited. For those who are interested you can book online at www.paediatric-trials.co.uk

SMi's Paediatric Clinical Trials conference has been running now for almost a decade. This year's conference will aim to deliver:

• Updates in negotiating pediatric investigation plans (PIPs) with the EMA
• Case study driven presentations highlighting industry experiences following on from the US pediatric legislation (FDASIA) from 2012
• The opportunity to meet a key member of the Paediatric Committee (PDCO) for unique insights into clinical trials
• Detailed specifics of vaccine clinical trials
• Hands-on experiences with pediatric clinical trials from the clinician’s and ethics committee’s point of view
• Updates on additional aspects of pediatric drug development: Pediatric Modelling & Simulation, Pediatric Dose Finding, Pediatric Research Networks, Pediatric Cardiology & Pediatric Psychiatry

Industry KOL Dr Klaus Rose, CEO from Klausrose Consulting commented:

"This conference will be a key event to discuss industry experience with the PIP procedure and lessons learned. Furthermore, we will reflect together which modifications would be desirable in the review of the EU pediatric legislation in 2018."

For further details and to register onto the conference, visit www.paediatric-trials.co.uk

Paediatric Clinical Trials
31st March & 1st April 2014
The Kensington Close Hotel, London UK

Teri Arri
SMi Group Ltd
+44 (0)20 7827 6162
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.